It has been previously suggested that juvenile hormone binding protein(s) (JHBP) belongs to a new class of proteins. In the search for other protein(s) that may contain structural motifs similar to those found in JHBP, hemolymph from Galleria mellonella (Lepidoptera) was chromatographed over a Sephadex G-200 column and resulting fractions were subjected to SDS-PAGE, transferred onto nitrocellulose membrane and scanned with a monoclonal antibody, mAb 104, against hemolymph JHBP. Two proteins yielded a positive reaction with mAb 104, one corresponding to JHBP and the second corresponding to a transferrin, as judged from N-terminal amino acid sequencing staining. Transferrin was purified to about 80% homogeneity using a two-step procedure including Sephadex G-200 gel filtration and HPLC MonoQ column chromatography. Panning of a random peptide display library and analysis with immobilized synthetic peptides were applied for finding a common epitope present in JHBP and the transferrin molecule. The postulated epitope motif recognized by mAb 104 in the JHBP sequence is RDTKAVN, and is localized at position 82-88.

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2001.129DOI Listing

Publication Analysis

Top Keywords

mab 104
12
juvenile hormone
8
hormone binding
8
galleria mellonella
8
sephadex g-200
8
jhbp
6
binding protein
4
transferrin
4
protein transferrin
4
transferrin galleria
4

Similar Publications

The most severe form of male infertility is idiopathic non-obstructive azoospermia (NOA), a complete sperm absence in the ejaculate. We performed exome sequencing in the Croatian infertile brothers with NOA and found a variant in DMRT1 (Doublesex and mab-3 related transcription factor 1) gene that was further assessed by the EMSA assay and molecular dynamic simulations. We additionally screened for DMRT1 mutations in 1940 infertile men diagnosed with spermatogenic failure, 644 normozoospermic controls, and 105 females with primary ovarian insufficiency (POI) recruited to the GEnetics of Male INfertility Initiative (GEMINI) or Estonian Andrology (ESTAND) cohorts.

View Article and Find Full Text PDF

Quantitative Assessment of Bony Fish Tropomyosin Using a Monoclonal Antibody Competitive ELISA.

J Agric Food Chem

December 2024

Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida 32306, United States.

Bony fish is one of the big-nine allergenic foods in the US. This study established a monoclonal antibody (mAb)-based indirect competitive enzyme-linked immunosorbent assay (ELISA) for the detection of bony fish tropomyosin (TM), a fish allergen. Immunoassay (Western blot and ELISA) was performed to characterize anti-TM mAb8F5 (target configuration, immunoaffinity, and species selectivity).

View Article and Find Full Text PDF

Background: There is a need for efficacious therapies for patients with Crohn's disease that are better tolerated and more durable than available treatments. We aimed to evaluate the efficacy and safety of filgotinib, an oral Janus kinase 1 preferential inhibitor, for treating Crohn's disease.

Methods: This phase 3, double-blind, randomised, placebo-controlled trial was conducted in 371 centres in 39 countries.

View Article and Find Full Text PDF
Article Synopsis
  • Statins are a primary treatment for heterozygous familial hypercholesterolemia, but there's concern they may increase the risk of type 2 diabetes; however, some studies suggest these patients might actually have a lower prevalence of diabetes.
  • A worldwide study analyzed data from nearly 25,000 adults with heterozygous familial hypercholesterolemia, looking at factors like age, BMI, and diabetes status while excluding certain groups to focus on the risk of type 2 diabetes.
  • The results showed a 5.7% prevalence of type 2 diabetes in the overall population studied, with a lower rate of 4.1% among those with genetically confirmed heterozygous familial hypercholesterolemia
View Article and Find Full Text PDF

Lyso-phosphatidylcholine as an interfacial stabilizer for parenteral monoclonal antibody formulations.

Eur J Pharm Biopharm

November 2024

Ludwig-Maximilians-Universität München, Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Butenandtstraße 5-13 B, 81377 Munich, Germany. Electronic address:

Therapeutic proteins suffer from physical and chemical instability in aqueous solution. Polysorbates and poloxamers are often added for protection against interfacial stress to prevent protein aggregation and particle formation. Previous studies have revealed that the hydrolysis and oxidation of polysorbates in parenteral formulations can lead to the formation of free fatty acid particles, insufficient long-term stabilization, and protein oxidation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!